THC-306EXT

A multicenter, open-label, extension trial to investigate long term efficacy and safety of lonapegsomatropin in adults with growth hormone deficiency.

Purpose

This is a phase 3 open-label multicenter extension trial designed to evaluate the long-term safety and efficacy of lonapegsomatropin administered once-weekly. The trial participants are adults (males and females) with confirmed GHD having completed the treatment period in trial TCH-306 (foresiGHt).